91 related articles for article (PubMed ID: 19158446)
1. Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study.
Ruhstaller T; von Moos R; Rufibach K; Ribi K; Glaus A; Spaeti B; Koeberle D; Mueller U; Hoefliger M; Hess D; Boehme C; Thuerlimann B
Oncology; 2009; 76(2):142-8. PubMed ID: 19158446
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).
Malinovszky KM; Cameron D; Douglas S; Love C; Leonard T; Dixon JM; Hopwood P; Leonard RC
Breast; 2004 Oct; 13(5):363-8. PubMed ID: 15454190
[TBL] [Abstract][Full Text] [Related]
3. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
Cella D; Fallowfield LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer.
Chin SN; Trinkaus M; Simmons C; Flynn C; Dranitsaris G; Bolivar R; Clemons M
Clin Breast Cancer; 2009 May; 9(2):108-17. PubMed ID: 19433392
[TBL] [Abstract][Full Text] [Related]
5. Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs).
Oberguggenberger A; Hubalek M; Sztankay M; Meraner V; Beer B; Oberacher H; Giesinger J; Kemmler G; Egle D; Gamper EM; Sperner-Unterweger B; Holzner B
Breast Cancer Res Treat; 2011 Jul; 128(2):553-61. PubMed ID: 21311968
[TBL] [Abstract][Full Text] [Related]
6. Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.
Schwartzberg LS; Cobb P; Senecal F; Henry D; Kulig K; Walker MS; Houts AC; Stepanski EJ
Breast; 2009 Apr; 18(2):78-83. PubMed ID: 19342237
[TBL] [Abstract][Full Text] [Related]
7. A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Kuroi K; Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Watanabe T; Bain S; Hausheer FH
Jpn J Clin Oncol; 2008 Nov; 38(11):748-54. PubMed ID: 18845520
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
9. Optimising care of elderly breast cancer patients: a challenging priority.
Tipples K; Robinson A
Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):118-30. PubMed ID: 19111450
[TBL] [Abstract][Full Text] [Related]
10. Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials.
Gueth U; Huang DJ; Schoetzau A; Holzgreve W; Wight E
Oncology; 2009; 76(4):247-53. PubMed ID: 19246949
[TBL] [Abstract][Full Text] [Related]
11. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
12. Ear acupuncture for hot flushes--the perceptions of women with breast cancer.
Walker G; de Valois B; Davies R; Young T; Maher J
Complement Ther Clin Pract; 2007 Nov; 13(4):250-7. PubMed ID: 17950180
[TBL] [Abstract][Full Text] [Related]
13. Relationship between severity of symptoms and quality of life in patients with breast cancer receiving adjuvant hormonal therapy.
Ochayon L; Zelker R; Kaduri L; Kadmon I
Oncol Nurs Forum; 2010 Sep; 37(5):E349-58. PubMed ID: 20797943
[TBL] [Abstract][Full Text] [Related]
14. [Breast cancer in the elderly].
Gutierrez M; Ben Abid F; Ousbane A; Gazzah A; Debled M; Girre V; Brain EG
Bull Cancer; 2008 May; 95 FMC Onco():F51-6. PubMed ID: 18511367
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer therapy: the role of PET-CT in decision making.
Pons F; Duch J; Fuster D
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):210-23. PubMed ID: 19293769
[TBL] [Abstract][Full Text] [Related]
16. Advances in hormonal therapy for breast cancer.
Bush NJ
Semin Oncol Nurs; 2007 Feb; 23(1):46-54. PubMed ID: 17303516
[TBL] [Abstract][Full Text] [Related]
17. Endocrine therapy in metastatic breast cancer: data from Breast Cancer Registry of Palermo, 1999-2005 .
Amodio R; Zarcone M; Agostara B; Staiti R; Granata OM; Carruba G; Traina A
Ann N Y Acad Sci; 2009 Feb; 1155():227-31. PubMed ID: 19250208
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy and hormonal therapy for older adults with breast cancer.
Hurria A
Semin Oncol; 2008 Dec; 35(6):618-24. PubMed ID: 19027465
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?
Freedman OC; Amir E; Clemons MJ
Crit Rev Oncol Hematol; 2009 Oct; 72(1):56-64. PubMed ID: 19307138
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.
Krause BJ; Herrmann K; Wieder H; zum Büschenfelde CM
J Nucl Med; 2009 May; 50 Suppl 1():89S-96S. PubMed ID: 19380406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
